Oluwole Fadare Selected Research

Endometrial Neoplasms (Endometrial Cancer)

12/2019	Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
10/2017	Intraoperative Pathologic Consultation on Hysterectomy Specimens for Endometrial Cancer: An Assessment of the Accuracy of Frozen Sections, "Gross-Only" Evaluations, and Obtaining Random Sections of a Grossly "Normal" Endometrium.
2/2014	Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
8/2013	The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.
4/2013	Salpingo-oophorectomy specimens for endometrial cancer staging: a comparative analysis of representative sampling versus whole tissue processing.
1/2013	Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases.
12/2012	Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
1/2012	Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment.
5/2011	Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events.
1/2009	Insights into endometrial serous carcinogenesis and progression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oluwole Fadare Research Topics

Disease

57	Neoplasms (Cancer) 08/2022 - 12/2002
27	Carcinoma (Carcinomatosis) 09/2022 - 06/2005
12	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2008
12	Endometrial Neoplasms (Endometrial Cancer) 12/2019 - 05/2005
8	Neoplasm Metastasis (Metastasis) 08/2022 - 03/2008
8	Endometrioid Carcinoma 01/2022 - 01/2009
6	Adenocarcinoma 09/2022 - 06/2005
5	Smooth Muscle Tumor 02/2022 - 07/2008
4	Teratoma (Teratoid Tumor) 09/2022 - 11/2004
4	Ovarian Neoplasms (Ovarian Cancer) 08/2022 - 08/2013
4	Carcinogenesis 01/2022 - 06/2005
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2018 - 08/2010
4	Leiomyosarcoma 01/2015 - 01/2008
3	Carcinosarcoma 12/2019 - 01/2012
3	Uterine Cervical Dysplasia 01/2018 - 09/2007
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 10/2004
3	Endometriosis 02/2015 - 01/2013
3	Pain (Aches) 02/2015 - 05/2007
3	Leiomyoma (Uterine Fibroids) 01/2015 - 07/2008
3	Fibrosis (Cirrhosis) 08/2014 - 09/2004
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2022 - 06/2015
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 09/2022 - 12/2019
2	Neoplasms, Cystic, Mucinous, and Serous 09/2022 - 08/2022
2	Polyps 01/2020 - 01/2019
2	Carcinoma in Situ 01/2017 - 01/2009
2	Angiomyolipoma 11/2014 - 10/2004
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2013 - 08/2009
2	Hemorrhage 01/2013 - 05/2006
2	Necrosis 07/2008 - 11/2006
2	Lobular Carcinoma 03/2008 - 11/2006
1	Colorectal Neoplasms (Colorectal Cancer) 08/2022
1	Peritoneal Diseases 08/2022
1	Appendiceal Neoplasms (Appendix Cancer) 08/2022
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 06/2022
1	Glucose Intolerance 01/2022
1	Nevi and Melanomas 03/2020
1	Pathologic Complete Response 01/2020
1	Extranodal Extension 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Triple Negative Breast Neoplasms 01/2020

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
12	Estrogen ReceptorsIBA 09/2022 - 11/2006
12	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2008
10	Progesterone Receptors (Progesterone Receptor)IBA 12/2019 - 11/2006
6	Biological ProductsIBA 01/2016 - 11/2005
5	Cadherins (E-Cadherin)IBA 01/2019 - 06/2005
4	Messenger RNA (mRNA)IBA 08/2015 - 02/2008
3	NucleotidesIBA 05/2022 - 03/2014
3	human ERBB2 proteinIBA 01/2021 - 11/2006
3	ParaffinIBA 03/2020 - 09/2011
3	Hormones (Hormone)IBA 01/2020 - 12/2017
3	Progestins (Progestagens)IBA 01/2019 - 05/2009
3	VimentinIBA 05/2014 - 03/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 11/2004
3	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2013 - 02/2008
3	Carrier Proteins (Binding Protein)IBA 08/2013 - 02/2008
3	antineoplaston A10 (A 10)IBA 01/2012 - 12/2006
3	Phenobarbital (Luminal)FDA Link 04/2011 - 09/2007
3	Keratins (Keratin)IBA 03/2010 - 11/2006
2	DesminIBA 02/2022 - 03/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	Estrogens (Estrogen)FDA Link 12/2019 - 08/2014
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 12/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 03/2010
2	AntigensIBA 11/2018 - 08/2010
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 03/2018 - 01/2008
2	Hepatocyte Nuclear Factor 1-betaIBA 02/2015 - 12/2012
2	Coenzyme A (CoA)IBA 02/2015 - 12/2013
2	Racemases and Epimerases (Epimerases and Racemases)IBA 02/2015 - 12/2013
2	Sirolimus (Rapamycin)FDA Link 01/2015 - 05/2011
2	Codon (Codons)IBA 01/2015 - 03/2014
2	StathminIBA 01/2015 - 06/2013
2	PlatinumIBA 08/2013 - 01/2012
2	Cisplatin (Platino)FDA LinkGeneric 08/2013 - 01/2012
2	Monoclonal AntibodiesIBA 01/2012 - 06/2005
2	Keratin-7 (Cytokeratin 7)IBA 08/2010 - 03/2010
1	CK 17IBA 08/2022
1	Keratin-17 (Keratin 17)IBA 08/2022
1	Calmodulin-Binding Proteins (Caldesmon)IBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2022
1	Vasopressins (Vasopressin)IBA 02/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Formaldehyde (Formol)FDA Link 03/2020
1	atezolizumabIBA 01/2020
1	villinIBA 12/2019

Therapy/Procedure

10	Hysterectomy 05/2022 - 05/2005
6	Therapeutics 01/2021 - 01/2009
4	Curettage 09/2022 - 02/2009
3	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 01/2017
2	Aftercare (After-Treatment) 09/2022 - 11/2004
2	Neoadjuvant Therapy 01/2020 - 12/2017
2	Drug Therapy (Chemotherapy) 05/2018 - 08/2013
2	Adjuvant Chemotherapy 01/2017 - 04/2013
2	Mammaplasty (Breast Reconstruction) 01/2014 - 09/2013
2	Salpingo-oophorectomy 04/2013 - 01/2013
2	Segmental Mastectomy (Lumpectomy) 04/2010 - 08/2009
1	Appendectomy 08/2022